Hinge Health, Inc.

  • Market Cap: Small Cap
  • Industry: Electronics & Appliances
  • ISIN: US4333131039
USD
35.41
-0.57 (-1.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

287.15 k

Shareholding (Dec 2025)

FII

11.66%

Held by 54 FIIs

DII

34.54%

Held by 25 DIIs

Promoter

33.12%

Is Hinge Health, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Hinge Health, Inc. shows a mildly bearish trend, supported by key indicators like Bollinger Bands and On-Balance Volume, with recent performance underperforming the S&P 500.

As of 24 October 2025, the technical trend for Hinge Health, Inc. has changed from sideways to mildly bearish. Key indicators supporting this stance include the weekly Bollinger Bands, Dow Theory, and On-Balance Volume (OBV), all indicating a mildly bearish outlook. The MACD and RSI show no signals on both weekly and monthly time frames, suggesting a lack of momentum. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of 0.65% and -8.54% respectively, compared to the S&P 500's returns of 1.92% and 2.32%.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Electronics & Appliances

stock-summary
Market cap

USD 3,428 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.95

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

9.05

Revenue and Profits:
Net Sales:
171 Million
(Quarterly Results - Dec 2025)
Net Profit:
31 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.11%
0%
-26.11%
6 Months
-28.88%
0%
-28.88%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Hinge Health, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
41.70%
EBIT Growth (5y)
-247.87%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.05
EV to EBIT
-5.65
EV to EBITDA
-5.71
EV to Capital Employed
179.35
EV to Sales
5.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3171.69%
ROE (Latest)
-111.23%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
Bollinger Bands
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 29 Schemes (20.68%)

Foreign Institutions

Held by 54 Foreign Institutions (11.66%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 10.70% vs 10.86% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1,827.78% vs 99.69% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "170.70",
          "val2": "154.20",
          "chgp": "10.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.70",
          "val2": "-3.70",
          "chgp": "902.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.20",
          "val2": "-1.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.10",
          "val2": "-1.80",
          "chgp": "1,827.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "166.70%",
          "val2": "-31.90%",
          "chgp": "19.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 50.59% vs 33.38% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3,463.87% vs 88.99% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "587.90",
          "val2": "390.40",
          "chgp": "50.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-535.90",
          "val2": "-18.50",
          "chgp": "-2,796.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.40",
          "val2": "-7.50",
          "chgp": "28.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-424.10",
          "val2": "-11.90",
          "chgp": "-3,463.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-920.30%",
          "val2": "-62.60%",
          "chgp": "-85.77%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
170.70
154.20
10.70%
Operating Profit (PBDIT) excl Other Income
29.70
-3.70
902.70%
Interest
0.00
0.00
Exceptional Items
-1.20
-1.20
Consolidate Net Profit
31.10
-1.80
1,827.78%
Operating Profit Margin (Excl OI)
166.70%
-31.90%
19.86%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 10.70% vs 10.86% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 1,827.78% vs 99.69% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
587.90
390.40
50.59%
Operating Profit (PBDIT) excl Other Income
-535.90
-18.50
-2,796.76%
Interest
0.00
0.00
Exceptional Items
-5.40
-7.50
28.00%
Consolidate Net Profit
-424.10
-11.90
-3,463.87%
Operating Profit Margin (Excl OI)
-920.30%
-62.60%
-85.77%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 50.59% vs 33.38% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -3,463.87% vs 88.99% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details